Pakistan to host pharma exhibition next week featuring over 100 foreign exhibitors

• The Dec. 2-4 event aims to promote technology, digitalization in Pakistan’s pharmaceutical sector
• Attendees will be able to engage in networking opportunities, gain insights from expert-led sessions

ISLAMABAD: The 23rd Pharma Asia International Exhibition 2025 will be held in Pakistan’s southern port city of Karachi from Dec. 2-4, state media reported on Saturday, aiming to promote technology and digitalization in the local pharma industry.

Pharma Asia Exhibition says on its website it will provide an “unparalleled platform” for industry professionals, leaders and innovators to showcase cutting-edge technologies, products, and services.

Attendees will have the chance to engage in networking opportunities, gain insights from expert-led sessions and stay abreast of the latest industry trends and advancements.

“The exhibition will feature over 750 stalls and 100 foreign exhibitors and is expected to be attended by many domestic and foreign pharma experts,” state broadcaster Radio Pakistan reported.

It said the event is being managed by an event management company named E-Commerce Gateway Pakistan (Pvt) Ltd, with support from the Pakistan Pharmaceutical Manufacturers Association (PPMA) and the Special Investment Facilitation Council (SIFC).

The SIFC is a hybrid, civil-military body formed by the government in 2023 to fast-track decisions related to international investment in Pakistan’s economic sectors such as tourism, livestock, agriculture, mines and minerals, and others.

The exhibition is aimed at promoting modern technology and digitalization in Pakistan’s pharma industry, Radio Pakistan said.

“Pharmaceutical machinery, raw materials, laboratory equipment and modern packaging solutions will be showcased at the event,” it said.

In September, the PPMA said Pakistan’s pharmaceutical industry posted a strong growth, with exports rising by 35 percent in the past year to nearly $500 million.

The pharma sector, which produces 90 percent of the country’s medicines domestically, is now looking to expand into new markets such as Afghanistan and scale up to global standards through digitization, technology transfer, and regulatory reform.